GlassScriptPhysician profile
Nikhil Thaker
NPI 1861782641
$1,967.57
in general payments reported to CMS, 2019-2025
16 companies · $1,316 in 2025
The $1,316 reported for 2025 was more than what 86% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $72.72 · 2021: $140 · 2022: $110 · 2023: $180 · 2025: $1,316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $962 · Food and Beverage: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $962.40 |
| Food and Beverage | $533.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $1,030.59 | 2025 | |
| Telix Pharmaceuticals | $151.33 | 2025 | Illuccix |
| Galvanize Therapeutics, INC | $133.67 | 2025 | Aliya System |
| Merck Sharp & Dohme LLC | $122.16 | 2021-2023 | Keytruda |
| Amgen INC. | $113.78 | 2019-2021 | |
| Incyte Corporation | $77.51 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $73.24 | 2019-2023 | Enhertu |
| Siemens Medical Solutions USA, INC. | $62.90 | 2023 | Varian Ethos Treatment Planning |
| Myovant Sciences INC. | $62.40 | 2021 | |
| Accuray Incorporated | $27.93 | 2023 | Tomo Therapy System, Cyberknife System |
| Seagen INC. | $26.92 | 2019-2023 | Adcetris |
| Secura Bio, INC. | $19.75 | 2019 | |
| Genzyme Corporation | $19.49 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $18.02 | 2019 | |
| Glaxosmithkline, LLC. | $16.00 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikhil Thaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.